PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'GlaxoSmithKline, Stevenage, Hertfordshire, UK.\', \'Statistical Innovation, Data Science, and Artificial Intelligence, AstraZeneca R&D, Gothenburg, Sweden.\', \'Section for Medical Statistics, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.\', \'Norwegian Medicines Agency, Oslo, Norway.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/cpt.2183
?:hasPublicationType
?:journal
  • Clinical pharmacology and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 33506495
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 169
?:title
  • Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal Outcome.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33506495>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33506495>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all